Building a Novel Antibiotic Stewardship intervention for nursing homes
为疗养院建立新型抗生素管理干预措施
基本信息
- 批准号:8744483
- 负责人:
- 金额:$ 49.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Up to 75% of antibiotic use in nursing homes is inappropriate. Inappropriate antibiotic use increases the nursing home resident's risk of adverse drug events, Clostridium difficile infection and infection with antibiotic- resistant bacteria, whih may then be spread to others. Results of antibiotic stewardship interventions in nursing homes have been mixed. While multi-component interventions targeting provider knowledge and aspects of the work system influencing prescribing decisions appear to reduce inappropriate antibiotic use in nursing homes, the mechanisms by which these interventions work is unclear. In the absence of this knowledge, successful dissemination of these interventions to other nursing home settings will not be possible. Consequently, there is a critical need for nursing home antibiotic stewardship studies that not only evaluate the impact of interventions on prescribing patterns but also evaluate the mechanisms by which they mediate change. Our long-term goal is to reduce inappropriate antibiotic use in nursing homes. Accordingly, our group has developed a novel antibiotic stewardship intervention that targets provider knowledge as well as important work system factors influencing antibiotic decision-making in nursing homes. The objectives of this particular application are to demonstrate the effectiveness of our antibioti stewardship intervention in nursing homes in two states and develop a resource to facilitate dissemination to other nursing home settings. We will achieve the objectives of this project through three specific aims: 1) tailor the antibiotic stewardship intervention for optimal implementation; 2) assess its impact on antibiotic use in study nursing homes; and 3) use knowledge gained to develop a dissemination toolkit. In the first aim, we will use human factors analyses to identify barriers and facilitators to implementation of the antibiotic stewardship intervention. Components of the intervention will be tailored to overcome these barriers and an implementation package will be developed with structured input from key informants in study nursing homes. In the second aim, the tailored antibiotic stewardship intervention will be implemented in study nursing homes using a quality improvement collaborative approach pioneered at the University of Wisconsin and antibiotic utilization measures will be compared with control facilities. In the third aim, knowledge generated from a mixed-methods assessment of intervention fidelity, sustainability and mechanisms by with the intervention mediates study outcomes will be used to develop a dissemination toolkit. The methods we will used to tailor our intervention and support its implementation (quality improvement collaborative) as well as the rigorous program evaluation we will employ to develop a dissemination toolkit are all innovative aspects of this proposal. The proposed research is significant; because it is expected to result in
a multi-faceted intervention that can be exported broadly to effectively reduce improve antibiotic use in facilities, which will, in turn, will reduce C. difficile infections and the emergence and spread of antibiotic resistance in nursing homes and the communities they serve.
描述(由申请人提供):疗养院中高达 75% 的抗生素使用是不适当的。不适当的抗生素使用会增加疗养院居民发生药物不良事件、艰难梭菌感染和抗生素耐药细菌感染的风险,这些风险可能会传播给其他人。疗养院抗生素管理干预的结果好坏参半。虽然针对提供者知识和影响处方决策的工作系统方面的多成分干预措施似乎可以减少疗养院中抗生素的不当使用,但这些干预措施的作用机制尚不清楚。如果缺乏这方面的知识,就不可能将这些干预措施成功传播到其他疗养院环境。因此,迫切需要开展疗养院抗生素管理研究,不仅要评估干预措施对处方模式的影响,还要评估干预措施调节变化的机制。我们的长期目标是减少疗养院中抗生素的不当使用。因此,我们的小组开发了一种新型抗生素管理干预措施,针对提供者的知识以及影响疗养院抗生素决策的重要工作系统因素。这一特定应用的目的是证明我们在两个州的疗养院中抗生素管理干预的有效性,并开发资源以促进向其他疗养院环境的传播。我们将通过三个具体目标来实现该项目的目标:1)定制抗生素管理干预措施以实现最佳实施; 2) 评估其对研究疗养院抗生素使用的影响; 3) 利用获得的知识开发传播工具包。第一个目标是,我们将利用人为因素分析来确定实施抗生素管理干预的障碍和促进因素。干预措施的组成部分将进行定制,以克服这些障碍,并将根据研究疗养院关键信息提供者的结构化意见制定实施方案。在第二个目标中,将使用威斯康星大学首创的质量改进协作方法在研究疗养院实施量身定制的抗生素管理干预措施,并将抗生素使用措施与对照设施进行比较。在第三个目标中,通过干预中介研究结果对干预保真度、可持续性和机制进行混合方法评估而产生的知识将用于开发传播工具包。我们将用于定制干预措施并支持其实施(质量改进协作)的方法以及我们将用于开发传播工具包的严格计划评估都是该提案的创新方面。拟议的研究意义重大;因为预计会导致
可以广泛输出的多方面干预措施,以有效减少设施中抗生素的使用,从而减少艰难梭菌感染以及疗养院及其服务社区中抗生素耐药性的出现和传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher J Crnich其他文献
Christopher J Crnich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher J Crnich', 18)}}的其他基金
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes
开发新型抗菌谱工具以改善疗养院的经验性抗生素处方
- 批准号:
10099724 - 财政年份:2020
- 资助金额:
$ 49.84万 - 项目类别:
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes
开发新型抗菌谱工具以改善疗养院的经验性抗生素处方
- 批准号:
10268207 - 财政年份:2020
- 资助金额:
$ 49.84万 - 项目类别:
Building a Novel Antibiotic Stewardship intervention for nursing homes
为疗养院建立新型抗生素管理干预措施
- 批准号:
8900251 - 财政年份:2014
- 资助金额:
$ 49.84万 - 项目类别:
相似国自然基金
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Leveraging evolutionary analyses and machine learning to discover multiscale molecular features associated with antibiotic resistance
利用进化分析和机器学习发现与抗生素耐药性相关的多尺度分子特征
- 批准号:
10658686 - 财政年份:2023
- 资助金额:
$ 49.84万 - 项目类别:
2023 Microbial Population Biology Gordon Research Conference and Gordon Research Seminar
2023年微生物种群生物学戈登研究会议暨戈登研究研讨会
- 批准号:
10753797 - 财政年份:2023
- 资助金额:
$ 49.84万 - 项目类别:
Mechanism Of Enterococcus Faecalis Nitro Drug Metabolism And In Vivo Implications
粪肠球菌硝基药物代谢机制及其体内影响
- 批准号:
10634708 - 财政年份:2022
- 资助金额:
$ 49.84万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10487660 - 财政年份:2022
- 资助金额:
$ 49.84万 - 项目类别:
High-throughput disulfide and FRET scanning to reveal protein conformational ensembles in vitro and in vivo.
高通量二硫键和 FRET 扫描可揭示体外和体内蛋白质构象整体。
- 批准号:
10191303 - 财政年份:2021
- 资助金额:
$ 49.84万 - 项目类别: